NLRP3 and colorectal cancer: Furthermore, IL-18 secretion mediated by the NLRP3 inflammasome can indirectly inhibit the tumor progression of colitis-associated colorectal cancer by inducing regulatory T (Treg) cells to produce IFN-γ and enhancing the cytotoxicity of T cells and NK cells (58).